Us Physicalrapy Stock Gross Profit

USPH Stock

USD 74.69 1.35 1.78%

US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.

	Last Reported	Projected for Next Year
Gross Profit	123.9 M	130.1 M
Gross Profit Margin	0.22	0.29

The US Physicalrapy's current Gross Profit is estimated to increase to about 130.1 M. The US Physicalrapy's current Gross Profit Margin is estimated to increase to 0.29.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

US Physicalrapy Company Gross Profit Analysis

US Physicalrapy's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current US Physicalrapy Gross Profit

146.13 M

Most of US Physicalrapy's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

USPH Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Gross Profit. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.72	0.88	0.86	0.89	0.98	0.87	0.83	0.98	-0.37	0.63	0.89	-0.3	0.93	0.04	0.08	-0.85	0.74	0.9	0.83	0.63	-0.86	0.88	0.87	0.14	0.78
Total Stockholder Equity	0.99		0.62	0.88	0.8	0.89	0.95	0.91	0.76	0.95	-0.44	0.68	0.84	-0.37	0.89	0.08	-0.01	-0.82	0.72	0.86	0.79	0.6	-0.83	0.88	0.86	0.24	0.8
Net Debt	0.72	0.62		0.75	0.86	0.51	0.82	0.55	0.9	0.65	-0.27	0.38	0.83	-0.25	0.77	0.11	0.15	-0.78	0.57	0.75	0.75	0.57	-0.81	0.53	0.66	-0.11	0.3
Retained Earnings	0.88	0.88	0.75		0.78	0.84	0.86	0.79	0.8	0.8	-0.69	0.81	0.77	-0.65	0.74	0.32	-0.23	-0.7	0.76	0.74	0.84	0.67	-0.91	0.67	0.66	0.0	0.5
Accounts Payable	0.86	0.8	0.86	0.78		0.74	0.92	0.65	0.81	0.86	-0.36	0.53	0.94	-0.3	0.94	0.07	0.02	-0.9	0.57	0.93	0.7	0.48	-0.75	0.7	0.79	-0.01	0.59
Net Receivables	0.89	0.89	0.51	0.84	0.74		0.82	0.7	0.58	0.9	-0.57	0.74	0.72	-0.49	0.73	0.14	-0.21	-0.62	0.72	0.76	0.68	0.55	-0.71	0.78	0.64	-0.01	0.72
Total Liab	0.98	0.95	0.82	0.86	0.92	0.82		0.83	0.89	0.96	-0.32	0.56	0.94	-0.25	0.96	0.02	0.12	-0.91	0.69	0.93	0.82	0.6	-0.85	0.87	0.89	0.11	0.74
Total Current Assets	0.87	0.91	0.55	0.79	0.65	0.7	0.83		0.64	0.78	-0.42	0.65	0.78	-0.38	0.79	0.15	-0.03	-0.78	0.62	0.77	0.74	0.57	-0.79	0.75	0.85	0.56	0.68
Short Term Debt	0.83	0.76	0.9	0.8	0.81	0.58	0.89	0.64		0.76	-0.22	0.4	0.77	-0.18	0.81	0.03	0.25	-0.76	0.61	0.72	0.82	0.61	-0.85	0.69	0.73	-0.15	0.47
Intangible Assets	0.98	0.95	0.65	0.8	0.86	0.9	0.96	0.78	0.76		-0.29	0.56	0.88	-0.21	0.93	-0.05	0.1	-0.84	0.67	0.91	0.74	0.54	-0.76	0.92	0.85	0.08	0.83
Good Will	-0.37	-0.44	-0.27	-0.69	-0.36	-0.57	-0.32	-0.42	-0.22	-0.29		-0.9	-0.3	0.99	-0.22	-0.64	0.83	0.21	-0.38	-0.25	-0.33	-0.25	0.39	-0.18	-0.17	0.01	-0.13
Common Stock	0.63	0.68	0.38	0.81	0.53	0.74	0.56	0.65	0.4	0.56	-0.9		0.51	-0.86	0.47	0.7	-0.64	-0.45	0.53	0.49	0.6	0.47	-0.56	0.45	0.51	0.08	0.51
Long Term Debt	0.89	0.84	0.83	0.77	0.94	0.72	0.94	0.78	0.77	0.88	-0.3	0.51		-0.24	0.96	0.04	0.05	-0.97	0.6	0.97	0.71	0.51	-0.76	0.79	0.88	0.24	0.65
Treasury Stock	-0.3	-0.37	-0.25	-0.65	-0.3	-0.49	-0.25	-0.38	-0.18	-0.21	0.99	-0.86	-0.24		-0.15	-0.64	0.84	0.15	-0.34	-0.18	-0.29	-0.23	0.36	-0.1	-0.1	0.0	-0.02
Property Plant Equipment	0.93	0.89	0.77	0.74	0.94	0.73	0.96	0.79	0.81	0.93	-0.22	0.47	0.96	-0.15		-0.05	0.16	-0.97	0.57	0.97	0.71	0.48	-0.75	0.83	0.92	0.2	0.75
Current Deferred Revenue	0.04	0.08	0.11	0.32	0.07	0.14	0.02	0.15	0.03	-0.05	-0.64	0.7	0.04	-0.64	-0.05		-0.58	-0.01	0.14	-0.03	0.34	0.33	-0.14	-0.1	0.15	-0.07	0.1
Short Term Investments	0.08	-0.01	0.15	-0.23	0.02	-0.21	0.12	-0.03	0.25	0.1	0.83	-0.64	0.05	0.84	0.16	-0.58		-0.11	0.03	0.08	0.16	0.17	-0.12	0.12	0.18	-0.02	0.11
Net Tangible Assets	-0.85	-0.82	-0.78	-0.7	-0.9	-0.62	-0.91	-0.78	-0.76	-0.84	0.21	-0.45	-0.97	0.15	-0.97	-0.01	-0.11		-0.52	-0.95	-0.68	-0.43	0.71	-0.76	-0.92	-0.3	-0.68
Total Permanent Equity	0.74	0.72	0.57	0.76	0.57	0.72	0.69	0.62	0.61	0.67	-0.38	0.53	0.6	-0.34	0.57	0.14	0.03	-0.52		0.59	0.8	0.78	-0.78	0.57	0.5	-0.03	0.42
Long Term Debt Total	0.9	0.86	0.75	0.74	0.93	0.76	0.93	0.77	0.72	0.91	-0.25	0.49	0.97	-0.18	0.97	-0.03	0.08	-0.95	0.59		0.69	0.46	-0.74	0.78	0.87	0.23	0.72
Capital Surpluse	0.83	0.79	0.75	0.84	0.7	0.68	0.82	0.74	0.82	0.74	-0.33	0.6	0.71	-0.29	0.71	0.34	0.16	-0.68	0.8	0.69		0.87	-0.92	0.62	0.74	-0.02	0.56
Deferred Long Term Liab	0.63	0.6	0.57	0.67	0.48	0.55	0.6	0.57	0.61	0.54	-0.25	0.47	0.51	-0.23	0.48	0.33	0.17	-0.43	0.78	0.46	0.87		-0.76	0.45	0.52	-0.05	0.38
Accumulated Depreciation	-0.86	-0.83	-0.81	-0.91	-0.75	-0.71	-0.85	-0.79	-0.85	-0.76	0.39	-0.56	-0.76	0.36	-0.75	-0.14	-0.12	0.71	-0.78	-0.74	-0.92	-0.76		-0.63	-0.68	-0.05	-0.43
Short Long Term Debt	0.88	0.88	0.53	0.67	0.7	0.78	0.87	0.75	0.69	0.92	-0.18	0.45	0.79	-0.1	0.83	-0.1	0.12	-0.76	0.57	0.78	0.62	0.45	-0.63		0.82	0.17	0.82
Net Invested Capital	0.87	0.86	0.66	0.66	0.79	0.64	0.89	0.85	0.73	0.85	-0.17	0.51	0.88	-0.1	0.92	0.15	0.18	-0.92	0.5	0.87	0.74	0.52	-0.68	0.82		0.36	0.85
Net Working Capital	0.14	0.24	-0.11	0.0	-0.01	-0.01	0.11	0.56	-0.15	0.08	0.01	0.08	0.24	0.0	0.2	-0.07	-0.02	-0.3	-0.03	0.23	-0.02	-0.05	-0.05	0.17	0.36		0.23
Capital Stock	0.78	0.8	0.3	0.5	0.59	0.72	0.74	0.68	0.47	0.83	-0.13	0.51	0.65	-0.02	0.75	0.1	0.11	-0.68	0.42	0.72	0.56	0.38	-0.43	0.82	0.85	0.23

Click cells to compare fundamentals

USPH Gross Profit Historical Pattern

Today, most investors in US Physicalrapy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various US Physicalrapy's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's gross profit growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of US Physicalrapy gross profit as a starting point in their analysis.

US Physicalrapy Gross Profit

Timeline

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict US Physicalrapy

Gross Profit Over Time

According to the company disclosure, US Physicalrapy reported 146.13 M of gross profit. This is 93.49% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 99.47% higher than that of the company.

USPH Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.

US Physicalrapy is currently under evaluation in gross profit category among its peers.

US Physicalrapy ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.

Environmental

Governance

Social

USPH Fundamentals

	Return On Equity	0.0646
	Return On Asset	0.0404
	Profit Margin	0.05 %
	Operating Margin	0.1 %
	Current Valuation	1.41 B
	Shares Outstanding	15.19 M
	Shares Owned By Insiders	1.94 %
	Shares Owned By Institutions	98.06 %
	Number Of Shares Shorted	538.49 K
	Price To Earning	34.35 X
	Price To Book	2.37 X
	Price To Sales	1.74 X
	Revenue	560.55 M
	Gross Profit	146.13 M
	EBITDA	86.91 M
	Net Income	45.6 M
	Cash And Equivalents	48.57 M
	Cash Per Share	3.73 X
	Total Debt	153.6 M
	Debt To Equity	0.57 %
	Current Ratio	1.43 X
	Book Value Per Share	32.39 X
	Cash Flow From Operations	74.94 M
	Short Ratio	4.77 X
	Earnings Per Share	1.84 X
	Price To Earnings To Growth	3.17 X
	Target Price	108.33
	Number Of Employees	4.03 K
	Beta	1.51
	Market Capitalization	1.16 B
	Total Asset	1.17 B
	Retained Earnings	227.26 M
	Working Capital	21.3 M
	Current Asset	60.18 M
	Current Liabilities	19.01 M
	Annual Yield	0.02 %
	Five Year Return	1.01 %
	Net Asset	1.17 B
	Last Dividend Paid	1.76

About US Physicalrapy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

V	Visa Class A
S	SentinelOne
GM	General Motors
MSFT	Microsoft
F	Ford Motor

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.76

Earnings Share

1.84

Revenue Per Share

44.107

Quarterly Revenue Growth

0.166

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Us Physicalrapy Stock Gross Profit

US Physicalrapy Company Gross Profit Analysis

Gross Profit

Revenue

-

Cost of Revenue

Current US Physicalrapy Gross Profit

USPH Gross Profit Driver Correlations

USPH Gross Profit Historical Pattern

USPH Gross Profit Peer Comparison

US Physicalrapy ESG Sustainability

USPH Fundamentals

About US Physicalrapy Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY